Showing results (31-40 of 84) with videos related to
Sort By:
Pageof 9
The American Journal of Managed Care|September 24, 2016
Mapping US commercial payers' coverage policies for medical interventionsJames D Chambers, Matthew D Chenoweth, Peter J NeumannHealth Affairs (Project Hope)|April 12, 2012
Therapies for advanced cancers pose a special challenge for health technology assessment organizations in many countriesPeter J Neumann, Sarah K Bliss, James D ChambersApplied Health Economics and Health Policy|December 18, 2022
The Value of New: Consideration of Product Novelty in Health Technology Assessments of PharmaceuticalsPatricia G Synnott, Dominic Voehler, Daniel E Enright, et al.Expert Review of Pharmacoeconomics & Outcomes Research|January 13, 2015
The lag from FDA approval to published cost-utility evidenceJames D Chambers, Teja Thorat, Junhee Pyo, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 28, 2023
Variation in Medicaid and commercial payer coverage of aducanumab for Alzheimer's diseasePei-Jung Lin, Adele Levine, Julia Rucker, et al.Journal of Vascular Surgery|August 3, 2012
Cost-effectiveness in the contemporary management of critical limb ischemia with tissue lossNeal R Barshes, James D Chambers, Joshua Cohen, et al.Journal of Managed Care & Specialty Pharmacy|April 3, 2025
Assessing variation in US payer coverage of anti-vascular endothelial growth factor therapies for the treatment of age-related macular degeneration, diabetic retinopathy, and diabetic macular edemaJames D Chambers, Molly T Beinfeld, Terry Richardson, et al.Health Affairs (Project Hope)|August 5, 2015
Private payers disagree with Medicare over medical device coverage about half the timeJames D Chambers, Matthew Chenoweth, Teja Thorat, et al.Gates Open Research|September 25, 2019
Comparing the cost-per-QALYs gained and cost-per-DALYs averted literaturesPeter J Neumann, Jordan E Anderson, Ari D Panzer, et al.Medical Care|December 24, 2011
Factors predicting Medicare national coverage: an empirical analysisJames D Chambers, Stephen Morris, Peter J Neumann, et al.Pageof 9